Acino ? Delivering Health
Acino ? Delivering Health
Acino ? Delivering Health
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Development projects<br />
Goserelin 1 & 3-month implant<br />
Target indication<br />
– (Advanced) prostate cancer (palliative treatment): Sixth leading cause of<br />
cancer-related death in men (globally), in the US it is the second<br />
– Breast cancer (1-month product, only)<br />
<strong>Acino</strong>’s timeline for target markets<br />
– Goserelin 1M launches in certain ROW markets end 2012/2013<br />
– Launch EU Q1-2015 (1-month product)<br />
– Launch EU Q1-2016 (3-month product)<br />
Reference product<br />
– Zoladex ® (Astra Zeneca)<br />
Competitor environment<br />
– No generic product of goserelin on the market<br />
– Only one competitor with implant in clinical phase<br />
26
Change language